Related Experiment Video
Updated: Feb 16, 2026
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
The dawn of vaccines for cancer prevention
1Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Abstract:
An important role of the immune system is in the surveillance for abnormal or transformed cells, which is known as cancer immunosurveillance. Through this process, the first changes to normal tissue homeostasis caused by infectious or other inflammatory insults can be detected by the immune system through the recognition of antigenic molecules (including tumour antigens) expressed by abnormal cells. However, as they develop, tumour cells can acquire antigenic and other changes that allow them to escape elimination by the immune system. To bias this process towards elimination, immunosurveillance can be improved by the administration of vaccines based on tumour antigens. Therapeutic cancer vaccines have been extensively tested in patients with advanced cancer but have had little clinical success, which has been attributed to the immunosuppressive tumour microenvironment. Thus, the administration of preventive vaccines at pre-malignant stages of the disease holds promise, as they function before tumour-associated immune suppression is established. Accordingly, immunological and clinical studies are yielding impressive results.
Insights
Preventive cancer vaccines show promise by targeting pre-malignant cells before immune suppression develops. This approach enhances cancer immunosurveillance, offering a new strategy for early cancer prevention.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- The immune system performs cancer immunosurveillance, detecting abnormal cells via antigenic molecules.
- Tumor cells can evade immune detection and elimination through acquired changes.
- Therapeutic cancer vaccines have shown limited success in advanced stages due to immunosuppressive tumor microenvironments.
Purpose of the Study:
- To explore the potential of preventive cancer vaccines administered at pre-malignant stages.
- To investigate strategies for enhancing cancer immunosurveillance before immune suppression is established.
Main Methods:
- Review of immunological and clinical studies on preventive cancer vaccines.
- Analysis of the mechanisms of cancer immunosurveillance and immune evasion.
Main Results:
- Preventive vaccines administered at pre-malignant stages show promise.
- These vaccines function effectively before the establishment of tumor-associated immune suppression.
- Immunological and clinical studies are yielding impressive results for this approach.
Conclusions:
- Preventive cancer vaccines represent a promising strategy for cancer control.
- Targeting pre-malignant stages may overcome the limitations of therapeutic vaccines.
- Further research and clinical studies are warranted to validate this approach.
Related Concept Videos
02:59Cancer Prevention
Some...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:51Vaccinations
01:14Prevention of Further Absorption of Poison
01:30Preventive Healthcare Services
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....